Anti-TNF therapy: where have we got to in 2005?
The blockade of TNF has had significant impact on the therapy of a number of chronic autoimmune diseases. In this chapter we review the concepts leading up to this therapy in rheumatoid arthritis (RA), how it spreads into other autoimmune diseases, and how greater understanding of its use has led to...
Main Authors: | Feldmann, M, Brennan, F, Foxwell, B, Taylor, P, Williams, R, Maini, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
by: Feldmann, M, et al.
Published: (2001) -
What have we learnt from targeted anti-TNF therapy?
by: Feldmann, M, et al.
Published: (2010) -
ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
by: Feldmann, M, et al.
Published: (2011) -
Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?
by: Samantha Turnbull, et al.
Published: (2015-12-01) -
TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
by: Maini, R, et al.
Published: (1993)